illumina inc (ILMN:NASDAQ GS)
Transactions by ILLUMINA INC (ILMN) in the last 6 months
Helix announced that it has received a round of funding on August 18, 2015. The transaction included participation from new investors Illumina Inc., Warburg Pincus LLC, and Sutter Hill Ventures for more than $100 million and Mayo Clinic. As part of the transaction, Jay Flatley, Chief Executive Officer of Illumina Inc. joined as the chairman of board of directors of the company.
Robert Langdon, Juliana Capata, Colin Lloyd, Lori Lesser, Genevieve Dorment, Katharine ...
Sutter Hill Ventures
Warburg Pincus LLC
Illumina Inc. (NasdaqGS:ILMN) entered into an agreement to acquire remaining stake in GenoLogics Life Sciences Software, Inc. from Yaletown Venture Partners Inc. and others on August 4, 2015. GenoLogics will become part of Illumina Enterprise Informatics business under the leadership of Sanjay Chikarmane, Senior Vice President and General Manager of Enterprise Informatics. The acquisition is expected to close by the end of August 2015.
Yaletown Venture Partners Inc.
Illumina Inc. (NasdaqGS:ILMN) announces a share repurchase program. Under the program, the company will repurchase up to $150 million worth of its common stock. The repurchases will be effected via Rule 10b5-1 rule plan. The repurchased shares which will be used to manage dilution from employee grants.
The Board of Directors of Illumina Inc. has authorized a buyback plan on May 1, 2015.
On May 1, 2015, the company initiated a Market Repurchase.
From May 1, 2015 ...
Twist Bioscience Corporation announced that it will receive $36,999,999 in equity funding on May 29, 2015. The company will issue securities pursuant to exemption provided under Regulation D.
Fidelity Management & Research Company
Foresite Capital Management, LLC
Paladin Capital Group
|Dr Reddy's Laboratories Ltd||4,228 INR||+40.55|
|Hologic Inc||$37.46 USD||-0.16|
|Sigma-Aldrich Corp||$139.60 USD||-0.05|
|Symrise AG||€55.34 EUR||-1.02|
|Waters Corp||$120.74 USD||+0.15|
|View Industry Companies|